# UCSF Helen Diller Family Comprehensive Cancer Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/ucsf-helen-diller-family-comprehensive-cancer-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 64.5 |
| Citations | 2,070,619 |
| City | San Francisco |
| Country | US |
| Description | UCSF Helen Diller Family Comprehensive Cancer Center is a research organisation in San Francisco, US. OpenAlex records 10,480 works and 2,070,619 citations for it. 1,472 researchers list it as their most recent affiliation. |
| Homepage | https://cancer.ucsf.edu/ |
| OpenAlex ID | https://openalex.org/I4210167126 |
| Researchers | 1,472 |
| ROR ID | https://ror.org/05yndxy10 |
| Type | facility |
| Works | 10,480 |

## University papers

- [Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-for-the-treatment-of-non-small-cell-lung-cancer/)
- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-1-2020/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing](https://scholariq.org/papers/therapy-induced-evolution-of-human-lung-cancer-revealed-by-single-cell-rna/)
- [Purification and Complementary DNA Cloning of a Receptor for Basic Fibroblast Growth Factor](https://scholariq.org/papers/purification-and-complementary-dna-cloning-of-a-receptor-for-basic-fibroblast/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)

## University top topics

Showing 8 of 25.

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.